Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Blood Coagul Fibrinolysis ; 31(3): 207-212, 2020 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-32108678

RESUMO

: Increasing the prevalence of cardiovascular disease (CVD) has led to an investigation into components that might influence CVD. Accordingly, many recent studies have reported the benefits of resveratrol (RSV). Therefore, this study aimed to scrutinize the direct effect of RSV on human umbilical vein endothelial cells (HUVECs) by detecting coagulative, fibrinolytic, and inflammatory markers. HUVECs were cultured and treated with different concentrations of RSV. The effects of RSV were identified by representative markers of coagulation, fibrinolysis pathway, and inflammation, including von Willebrand factor (VWF), factor VIII, tissue plasminogen activator-1 (t-PA-1), and interleukin-8 (IL-8). The detection process was carried out using real-time PCR (qPCR), flow cytometry, ELISA, and immunocytochemistry (ICC) methods. The present findings demonstrated a significant decrease in VWF, t-PA-1, and IL-8 secretion levels. Furthermore, RSV diminished the activity of factor VIII and mRNA expression levels of VWF and t-PA-1. The ICC results also showed a decrease in the level of intracellular t-PA. Our data revealed the anti-inflammatory, anticoagulation, and antifibrinolytic effect of RSV in cell culture.


Assuntos
Antioxidantes/uso terapêutico , Coagulação Sanguínea/efeitos dos fármacos , Endotélio Vascular/metabolismo , Fibrinólise/efeitos dos fármacos , Células Endoteliais da Veia Umbilical Humana/metabolismo , Imuno-Histoquímica/métodos , Inflamação/tratamento farmacológico , Resveratrol/uso terapêutico , Antioxidantes/farmacologia , Humanos , Resveratrol/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...